PortfoliosLab logoPortfoliosLab logo
EDC vs. CURE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

EDC vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Emerging Markets Bull 3X Shares (EDC) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, EDC achieves a 29.40% return, which is significantly higher than CURE's 1.16% return. Over the past 10 years, EDC has underperformed CURE with an annualized return of 3.27%, while CURE has yielded a comparatively higher 12.86% annualized return.


EDC

1D
1.26%
1M
-30.12%
6M
10.38%
YTD
29.40%
1Y
73.57%
3Y*
33.61%
5Y*
-4.06%
10Y*
3.27%
ALL TIME*
1.37%

CURE

1D
-3.42%
1M
20.37%
6M
-0.05%
YTD
1.16%
1Y
55.41%
3Y*
2.89%
5Y*
1.12%
10Y*
12.86%
ALL TIME*
23.83%
*Multi-year figures are annualized to reflect compound growth (CAGR)

EDC vs. CURE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
EDC
Direxion Daily Emerging Markets Bull 3X Shares
29.40%94.58%-2.00%7.48%-60.25%-20.81%6.49%43.92%-49.87%138.61%
CURE
Direxion Daily Healthcare Bull 3x Shares
1.16%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%

Correlation

The correlation between EDC and CURE is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (5Y)
Calculated over the trailing 5-year period

0.29

Correlation (10Y)
Calculated over the trailing 10-year period

0.40

Correlation (All Time)
Calculated using the full available price history since Jun 15, 2011

0.46

Over the past year, the correlation between EDC and CURE has dropped to 0.09 - well below their long-term average of 0.46, suggesting their price drivers have been diverging.

EDC vs. CURE - Sectors Allocation Comparison


Sectors
EDC
CURE

Technology

32.7%

-

Financial Services

20.8%

-

Consumer Cyclical

10.3%

-

Communication Services

7.8%

-

Industrials

7.3%

-

Basic Materials

7.0%

-

Energy

4.4%

-

Consumer Defensive

3.2%

-

Healthcare

3.2%
100.0%

Utilities

2.2%

-

Real Estate

1.1%

-

Technology

EDC
32.7%
CURE

-

Financial Services

EDC
20.8%
CURE

-

Consumer Cyclical

EDC
10.3%
CURE

-

Communication Services

EDC
7.8%
CURE

-

Industrials

EDC
7.3%
CURE

-

Basic Materials

EDC
7.0%
CURE

-

Energy

EDC
4.4%
CURE

-

Consumer Defensive

EDC
3.2%
CURE

-

Healthcare

EDC
3.2%
CURE
100.0%

Utilities

EDC
2.2%
CURE

-

Real Estate

EDC
1.1%
CURE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EDC vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EDC
EDC Risk / Return Rank: 4444
Overall Rank
EDC Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
EDC Sortino Ratio Rank: 4040
Sortino Ratio Rank
EDC Omega Ratio Rank: 4646
Omega Ratio Rank
EDC Calmar Ratio Rank: 5151
Calmar Ratio Rank
EDC Martin Ratio Rank: 4747
Martin Ratio Rank

CURE
CURE Risk / Return Rank: 4444
Overall Rank
CURE Sharpe Ratio Rank: 4545
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 5151
Sortino Ratio Rank
CURE Omega Ratio Rank: 4343
Omega Ratio Rank
CURE Calmar Ratio Rank: 4646
Calmar Ratio Rank
CURE Martin Ratio Rank: 3535
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EDC vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Emerging Markets Bull 3X Shares (EDC) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


EDCCUREDifference
Sharpe ratioReturn per unit of total volatility

-0.15

Sortino ratioReturn per unit of downside risk

-0.31

Omega ratioGain probability vs. loss probability

1.23

1.21

+0.01

Calmar ratioReturn relative to maximum drawdown

1.95

1.79

+0.16

Martin ratioReturn relative to average drawdown

5.75

3.98

+1.77

EDC vs. CURE - Sharpe Ratio Comparison

The current EDC Sharpe Ratio is 1.04, which is comparable to the CURE Sharpe Ratio of 1.19. The chart below compares the historical Sharpe Ratios of EDC and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

EDC vs. CURE - Drawdown Comparison

The maximum EDC drawdown since its inception was -92.54%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for EDC and CURE.


Loading charts...

Drawdown Indicators


EDCCUREDifference

Max Drawdown

Largest peak-to-trough decline

-92.54%

-69.19%

-23.35%

Max Drawdown (1Y)

Largest decline over 1 year

-37.98%

-31.10%

-6.88%

Max Drawdown (3Y)

Largest decline over 3 years

-49.48%

-51.93%

+2.45%

Max Drawdown (5Y)

Largest decline over 5 years

-78.04%

-52.23%

-25.81%

Max Drawdown (10Y)

Largest decline over 10 years

-87.01%

-69.19%

-17.82%

Current Drawdown

Current decline from peak

-72.54%

-19.70%

-52.84%

Average Drawdown

Average peak-to-trough decline

-65.36%

-18.17%

-47.19%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.83%

13.96%

-1.13%

Volatility

EDC vs. CURE - Volatility Comparison

Direxion Daily Emerging Markets Bull 3X Shares (EDC) has a higher volatility of 30.64% compared to Direxion Daily Healthcare Bull 3x Shares (CURE) at 18.53%. This indicates that EDC's price experiences larger fluctuations and is considered to be riskier than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EDCCUREDifference

Volatility (1M)

Calculated over the trailing 1-month period

30.64%

18.53%

+12.11%

Volatility (6M)

Calculated over the trailing 6-month period

65.69%

34.70%

+30.99%

Volatility (1Y)

Calculated over the trailing 1-year period

71.09%

46.73%

+24.36%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

59.15%

44.52%

+14.63%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

61.36%

49.77%

+11.59%

EDC vs. CURE - Expense Ratio Comparison

EDC has a 1.33% expense ratio, which is higher than CURE's 1.08% expense ratio.


Dividends

EDC vs. CURE - Dividend Comparison

EDC's dividend yield for the trailing twelve months is around 1.53%, more than CURE's 1.12% yield.


PositionTTM202520242023202220212020201920182017
CURE
Direxion Daily Healthcare Bull 3x Shares
1.12%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%
EDC
Direxion Daily Emerging Markets Bull 3X Shares
1.53%1.79%3.94%3.54%0.00%0.18%0.44%0.97%0.78%0.25%

Frequently Asked Questions


EDC and CURE have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

EDC has higher volatility (30.64%) compared to CURE (18.53%). In terms of maximum drawdown, EDC dropped -92.54% vs CURE's -69.19%.

On 10-year performance, CURE leads with 12.86% vs 3.27% for EDC. On fees, CURE is cheaper at 1.08% per year. On volatility, CURE has been the lower-risk option at 18.53%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, CURE has performed better with a 12.86% return vs 3.27%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

CURE is cheaper with a 1.08% expense ratio, compared with 1.33% for EDC.

EDC has the higher dividend yield at 1.53%, compared with 1.12% for CURE.

EDC tracks MSCI Emerging Markets Index (300%), while CURE tracks Health Care Select Sector Index (300%). Their fees differ too: 1.33% for EDC and 1.08% for CURE.

CURE currently has the higher Sharpe Ratio (1.19 vs 1.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for EDC and CURE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer